Related Experiment Video
Updated: Aug 17, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Interferon as an adjuvant treatment for genital condyloma acuminatum
1Department of Obstetrics and Gynecology, Women's and Children's Hospital, USC School of Medicine, Los Angeles, USA.
Objective:
To evaluate the effect of alpha-interferon as an adjuvant to laser or fluorouracil treatment in patients with recurrent genital human papillomavirus (HPV) infection.
Methods:
Sixty-two females and 21 males were treated for recurrent HPV infection, with either fluorouracil (Efudex 5%) cream or laser ablation of the lesions. Half of the patients were then randomly treated with adjuvant alpha-interferon, to the lesions for patients treated with fluorouracil, or beneath areas previously treated by laser, once a week, for 8 weeks. The other half of the patients did not receive interferon adjuvant. Evaluation of both groups was done using colposcopy and acetic acid, to assess recurrence rates up to 1 year after treatment.
Results:
Of the 83 patients followed for 1 year, colposcopy revealed recurrent anogenital lesions in 3 of 45 receiving interferon, compared with 9 of 38 patients treated without adjuvant interferon.
Conclusion:
Interferon is effective as adjuvant treatment in controlling the recurrence of genital HPV.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Sexually Transmitted Infections
Genital Herpes
Trichomoniasis
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

